SG10201401131WA - Decellularization and recellularization of organs and tissues - Google Patents

Decellularization and recellularization of organs and tissues

Info

Publication number
SG10201401131WA
SG10201401131WA SG10201401131WA SG10201401131WA SG10201401131WA SG 10201401131W A SG10201401131W A SG 10201401131WA SG 10201401131W A SG10201401131W A SG 10201401131WA SG 10201401131W A SG10201401131W A SG 10201401131WA SG 10201401131W A SG10201401131W A SG 10201401131WA
Authority
SG
Singapore
Prior art keywords
recellularization
decellularization
organs
tissues
Prior art date
Application number
SG10201401131WA
Inventor
Doris Taylor
Harald Ott
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of SG10201401131WA publication Critical patent/SG10201401131WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00—Bioreactors or fermenters specially adapted for specific uses
    • C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14—Scaffolds; Matrices
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
SG10201401131WA 2009-03-31 2010-03-31 Decellularization and recellularization of organs and tissues SG10201401131WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21161309P 2009-03-31 2009-03-31

Publications (1)

Publication Number Publication Date
SG10201401131WA true SG10201401131WA (en) 2014-07-30

Family

ID=42983078

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201401131WA SG10201401131WA (en) 2009-03-31 2010-03-31 Decellularization and recellularization of organs and tissues
SG2011070810A SG174969A1 (en) 2009-03-31 2010-03-31 Decellularization and recellularization of organs and tissues

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011070810A SG174969A1 (en) 2009-03-31 2010-03-31 Decellularization and recellularization of organs and tissues

Country Status (12)

Country Link
US (2) US20120183944A1 (en)
EP (1) EP2413946A2 (en)
JP (6) JP2012522511A (en)
KR (1) KR20120023626A (en)
CN (1) CN102448476A (en)
AU (1) AU2010236855C1 (en)
CA (1) CA2757457C (en)
IL (1) IL215463A0 (en)
MX (1) MX2011010197A (en)
RU (1) RU2011143730A (en)
SG (2) SG10201401131WA (en)
WO (1) WO2010120539A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG170731A1 (en) * 2005-08-26 2011-05-30 Univ Minnesota Decellularization and recellularization of organs and tissues
WO2012005760A1 (en) * 2010-06-30 2012-01-12 Miromatrix Medical Inc. Use of perfusion decellularized organs for matched recellularization
EP2611472B1 (en) 2010-09-01 2016-02-10 Regents of the University of Minnesota Methods of recellularizing a tissue or organ for improved transplantability
EP2714894B1 (en) * 2011-05-27 2019-10-30 DePuy Synthes Products, Inc. Bioartificial proximal tubule systems and methods of use
CN103173920B (en) * 2011-12-26 2014-08-27 广野精机有限公司 Weft yarn conveying thread control device
EP2809152B1 (en) 2012-02-01 2019-11-20 Nayacure Therapeutics Ltd Method for inducing immune tolerance to organ transplants
US20150093812A1 (en) * 2012-04-18 2015-04-02 The General Hospital Corporation Bioartificial filtration organ
WO2013163358A1 (en) 2012-04-24 2013-10-31 Harvard Bioscience, Inc. Engineered tissue scaffolds and supports therefor
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
US10111740B2 (en) 2012-08-21 2018-10-30 Regents Of The University Of Minnesota Decellularized biologically-engineered tubular grafts
EP2943231A4 (en) 2013-01-09 2016-12-07 Harvard Apparatus Regenerative Tech Inc Synthetic scaffolds
BR112015023642A2 (en) * 2013-03-15 2017-07-18 Miromatrix Medical Inc use of decellularized liver perfusion to allow cell recellularization
US9888680B2 (en) 2013-04-04 2018-02-13 The Trustees Of Columbia University In The City Of New York Functional recovery of human lungs for transplantation
RU2539918C1 (en) * 2013-11-29 2015-01-27 Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации Method for preparing tissue-specific matrix for tissue engineering of parenchymal organ
CN103751843B (en) * 2013-12-05 2015-09-16 南方医科大学珠江医院 Prepare the test kit of full liver biological support and full liver biological support preparation method
KR101637548B1 (en) 2013-12-24 2016-07-20 연세대학교 산학협력단 Decellularized organ matrix grinding powder and the method for preparing thereof
ES2841142T3 (en) * 2014-03-14 2021-07-07 Massachusetts Gen Hospital Lung bioreactor
CN103966092A (en) * 2014-04-10 2014-08-06 欧东波 Organ decellularization and circular fusion regeneration culture bottle
JP2016524954A (en) * 2014-05-27 2016-08-22 ノーバヘップ アーベー Allogeneic valves produced by biotechnology
CN107105639A (en) * 2014-09-02 2017-08-29 联合治疗学有限公司 Automated biological reaction device system, automatic organ of implementing goes cell protocol system, and waste sanitation system
US20170240854A1 (en) * 2014-09-23 2017-08-24 Nanyang Technological University A bioreactor module, a bioreactor system and methods for thick tissue seeding and cultivation in an hirearchical organization and physiological mimiking conditions
JP2016185115A (en) * 2015-03-27 2016-10-27 シスメックス株式会社 Organ perfusion method and organ perfusion apparatus
CN106148270B (en) * 2015-04-13 2019-09-06 中国科学院大连化学物理研究所 A kind of construction method of the micro- hepatic tissue unit of three-dimensional for biological artificial liver support system
CN104771788B (en) * 2015-05-05 2017-08-25 北京帝康医药投资管理有限公司 A kind of organization engineering skin and its construction method based on omentum majus acellular matrix
CN106693055A (en) * 2015-07-26 2017-05-24 复旦大学附属华山医院 Cerebellar decellularized regeneration biological scaffold, preparation method and application thereof
US10731135B2 (en) 2015-09-11 2020-08-04 The General Hospital Corporation Regeneration of a functional pulmonary vascular bed
WO2017136786A1 (en) * 2016-02-05 2017-08-10 The Trustees Of Columbia University In The City Of New York Rigionally specific tissua-derived extracellular metrix
ES2925746T3 (en) 2016-04-05 2022-10-19 Univ Minnesota Modified fabrics having structural components incorporated therein, and methods of manufacture and use
ITUA20164238A1 (en) * 2016-06-09 2017-12-09 G F S P A METHOD AND APPARATUS FOR THE DECELLULARIZATION OF ORGANS
CN107621462B (en) * 2016-07-13 2020-03-31 王志伟 Tissue clearing liquid SUT and preparation and application thereof
CN106267345B (en) * 2016-08-04 2019-03-26 中国人民解放军第三军医大学第一附属医院 A kind of preparation method of biologically active regeneration period organ acellular organism bracket and products thereof and application
WO2018048899A1 (en) * 2016-09-06 2018-03-15 Micromatrix Medical Inc. Use of resected liver serum for whole liver engineering
CN107412865A (en) * 2016-10-27 2017-12-01 浙江保尔曼生物科技有限公司 The decellularization kidney biological support and preparation method with anticoagulant functions of high intensity
CN107096070B (en) * 2017-03-09 2020-08-21 中国医学科学院阜外医院 Decellularized lung scaffold and preparation method thereof
CN108465126A (en) * 2018-05-25 2018-08-31 中国人民解放军总医院 Simulate the preparation facilities of the bladder acellular matrix of physiology course
JP7425485B2 (en) 2019-01-30 2024-01-31 国立大学法人 長崎大学 disease model
EP3941497A4 (en) * 2019-03-21 2022-12-21 Miromatrix Medical Inc. Improved decellularization of isolated organs
CA3191775A1 (en) * 2020-09-04 2022-03-10 Narendra R. Vyavahare Systems and methods for processing tissue
CN114949357B (en) * 2022-05-20 2023-08-01 上海市第十人民医院 Penis decellularized scaffold and preparation method and application thereof
WO2024104780A1 (en) 2022-11-18 2024-05-23 Baxter Healthcare Sa Extracorporeal blood treatment for organ support
CN117100912A (en) * 2023-06-08 2023-11-24 北京科昕恒业生物科技有限公司 Lung acellular matrix and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1176400A (en) * 1997-09-09 1999-03-23 Masahito Nagaki Artificial organ
JP4222658B2 (en) * 1998-06-23 2009-02-12 テルモ株式会社 Cell support substrate, culture apparatus and liquid processing apparatus
US20050249816A1 (en) * 1999-12-29 2005-11-10 Wake Forest University Health Services Tissue engineered liver constructs
US6479064B1 (en) * 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
CA2445110A1 (en) * 2001-05-01 2002-11-07 Universite Du Quebec A Montreal Tridimensional biocompatible support structure for bioartificial organs and uses thereof
WO2003085100A1 (en) * 2002-04-04 2003-10-16 Daiichi Pure Chemicals Co., Ltd. Method of culturing liver cells over long time
WO2006126219A1 (en) * 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
US7824912B2 (en) * 2005-06-23 2010-11-02 Massachusetts Institute Of Technology Methods for ex vivo propagation of adult hepatic stem cells
SG170731A1 (en) * 2005-08-26 2011-05-30 Univ Minnesota Decellularization and recellularization of organs and tissues
JP4599315B2 (en) * 2006-02-23 2010-12-15 クラレメディカル株式会社 Bioartificial organ

Also Published As

Publication number Publication date
AU2010236855B2 (en) 2014-09-11
EP2413946A2 (en) 2012-02-08
US20220062349A1 (en) 2022-03-03
JP2017195900A (en) 2017-11-02
MX2011010197A (en) 2011-11-18
JP2022107023A (en) 2022-07-20
CN102448476A (en) 2012-05-09
US20120183944A1 (en) 2012-07-19
WO2010120539A2 (en) 2010-10-21
JP2012522511A (en) 2012-09-27
JP2024015176A (en) 2024-02-01
CA2757457C (en) 2018-05-29
AU2010236855C1 (en) 2015-04-02
AU2010236855A1 (en) 2011-10-27
JP2019134723A (en) 2019-08-15
CA2757457A1 (en) 2010-10-21
RU2011143730A (en) 2013-05-10
KR20120023626A (en) 2012-03-13
JP2016039903A (en) 2016-03-24
IL215463A0 (en) 2011-12-29
WO2010120539A3 (en) 2011-02-03
SG174969A1 (en) 2011-11-28

Similar Documents

Publication Publication Date Title
IL215463A0 (en) Decellularization and recellularization of organs and tissues
IL212944A0 (en) Photothermal treatment of soft tissues
EP2414508A4 (en) Tissue and organ graft bioreactor and method of operation
EP2482761A4 (en) Tissue transplant compositions and methods for use
IL237376A0 (en) Surgical sutures and method of fabrication thereof
EP2326335A4 (en) Composition for a tissue repair implant and methods of making the same
EP2268209A4 (en) Methods and devices to decrease tissue trauma during surgery
HK1199812A1 (en) Platform for engineered implantable tissues and organs and methods of making the same
EP2513299A4 (en) Decellularized adipose tissue
PL2588592T3 (en) Use of perfusion decellularized organs for matched recellularization
EP2291110A4 (en) Methods and devices to decrease tissue trauma during surgery
EP2252686A4 (en) Compositions and methods for implantation of adipose tissue and adipose tissue products
EP2381887A4 (en) Implants and procedures for supporting anatomical structures for treating conditions such as pelvic organ prolapse
EP2358301A4 (en) Regenerative tissue grafts and methods of making same
EP2262450A4 (en) Implants and methods of use
IL217357A0 (en) Vascular and bodily duct treatment devices and methods
ZA201103723B (en) Human antibodies against human tissue factor
EP2427128A4 (en) Surgical patch cover and method of use
ZA201202143B (en) Coreless tissue rolls and method of making the same
IL219650A0 (en) Surgical needle coatings and methods
EP2234628A4 (en) Compositions and methods of promoting wound healing
EP2498798A4 (en) Compositions and methods for wound treatment
IL219652A0 (en) Surgical needle coatings and methods
HK1171677A1 (en) Composition for the treatment of hemorrhoids and related diseases
IL219651A0 (en) Surgical needle coatings and methods